Haemonetics Reports 4th Quarter Fiscal 2015 Revenue of $226 Million and Adjusted EPS of $0.47; Full Year Revenue of $910 Million and Adjusted EPS of $1.85; Provides Fiscal 2016 Guidance
Go back to Haemonetics Reports 4th Quarter Fiscal 2015 Revenue of $226 Million and Adjusted EPS of $0.47; Full Year Revenue of $910 Million and Adjusted EPS of $1.85; Provides Fiscal 2016 Guidance| HAEMONETICS CORPORATION (NYSE: HAE) | Delayed: 102.92 +0.07 (0.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $102.85 | 52 Week High | $39.41 | |||
| Open | $101.59 | 52 Week Low | $25.98 | |||
| Day High | $103.57 | P/E | 144.96 | |||
| Day Low | $101.51 | EPS | $0.71 | |||
| Volume | 425,088 | |||||
